Systematic Financial Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-134,442
| Closed | -$1.32M | – | 726 |
|
|
2017
Q1 | $1.32M | Sell |
134,442
-32,365
| -19% | -$317K | 0.02% | 563 |
|
|
2016
Q4 | $1.8M | Buy |
166,807
+7,180
| +4% | +$77.6K | 0.03% | 411 |
|
|
2016
Q3 | $1.64M | Buy |
159,627
+19,750
| +14% | +$202K | 0.02% | 473 |
|
|
2016
Q2 | $1.83M | Sell |
139,877
-4,315
| -3% | -$56.3K | 0.02% | 373 |
|
|
2016
Q1 | $1.59M | Sell |
144,192
-20,840
| -13% | -$229K | 0.02% | 457 |
|
|
2015
Q4 | $1.52M | Sell |
165,032
-108,640
| -40% | -$999K | 0.02% | 502 |
|
|
2015
Q3 | $1.9M | Sell |
273,672
-6,385
| -2% | -$44.3K | 0.02% | 520 |
|
|
2015
Q2 | $2.75M | Sell |
280,057
-7,343
| -3% | -$72.1K | 0.02% | 365 |
|
|
2015
Q1 | $2.55M | Buy |
287,400
+23,375
| +9% | +$207K | 0.02% | 444 |
|
|
2014
Q4 | $2.31M | Buy |
+264,025
| New | +$2.31M | 0.02% | 464 |
|